Biodefense Stock Alert: PositiveID (OTCBB:PSID) Reports Issuance of Draft RFP From Dept of Homeland Security for BioWatch Generation 3

DELRAY BEACH, Fla. - February 7, 2013 (Investorideas.com Newswire) PositiveID Corporation (OTCBB: PSID), a developer of biological detection and diagnostics solutions, today announced that the U.S. Department of Homeland Security ("DHS") released a draft request for proposal ("RFP") for Stage 1 of BioWatch Generation 3, an autonomous biodetection system designed to protect the nation against biological threats. The final RFP for Stage 1 is expected to be released in the government's third quarter of fiscal 2013, which ends June 30th. The Stage 1 contract is expected to have a performance period of 18 months. The full roll-out of BioWatch Generation 3 is estimated at $3.1 billion over the next five years.

William J. Caragol, Chairman and CEO of PositiveID, stated, "We believe that PositiveID is well positioned for BioWatch Generation 3, as our M-BAND detection technology (Microfluidics-based BioAgent Autonomous Networked Detector) was the only system of its kind successfully demonstrated in the field as part of the DHS Science & Technology Directorate ("S&T") BAND (BioAgent Autonomous Networked Detector) Program. In October 2012, we issued a corporate update to our stockholders about the BioWatch program, stating that we were in discussions with strategic partners to manufacture and sell M-BAND, and reiterating our belief that the BioWatch program would soon begin to roll out. The release of the draft RFP for Stage 1 of BioWatch Generation 3 validates this belief and re-confirms the U.S. Government's focus on protecting the nation from biological threats. Moreover, in the fourth quarter of 2012, we announced that we entered into two agreements with large strategic partners that we believe position us effectively to deliver critical detection systems for our homeland defense."
For more information on these announcements, please click on the following links:
http://investors.positiveidcorp.com/releasedetail.cfm?ReleaseID=728046
http://investors.positiveidcorp.com/releasedetail.cfm?ReleaseID=718902
About M-BAND and Dragonfly
PositiveID's M-BAND technology, developed under contract with DHS S&T, is a bio-aerosol monitor with fully integrated systems for sample collection, processing and detection modules that continuously analyze air samples for the detection of bacteria, viruses, and toxins. Results are reported via a secure wireless network in real time to give an accurate and up to date status for fielded instruments. PositiveID's Dragonfly system is designed to deliver molecular diagnostic results from a sample in less than 30 minutes, which would enable accurate diagnostics leading to potential treatment scenarios at the point of care that are not possible with existing systems. Dragonfly is being developed further for a broad range of biological detection situations including radiation-induced cell damage within the human body, strains of influenza and other common pathogens and diseases such as E. coli, methicillin-resistant staphylococcus aureus ("MRSA") and human papilloma virus ("HPV").
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of biological detection and diagnostics systems for America's homeland defense industry as well as rapid medical testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. For more information on PositiveID, please visit http://www.PositiveIDCorp.com.
Statements about PositiveID's future expectations, including, without limitation, the likelihood that the final RFP for Stage 1 of BioWatch Generation 3 is expected to be released in the government's third quarter of fiscal 2013, which ends June 30th; the likelihood that the Stage 1 contract is expected to have a performance period of 18 months; the likelihood that the full roll-out of BioWatch Generation 3 is estimated at $3.1 billion; the likelihood that PositiveID is well positioned for BioWatch Generation 3 as its M-BAND detection technology was the only system of its kind successfully demonstrated in the field as part of the DHS S&T BAND Program; the likelihood that the Company's two agreements with large strategic partners position the Company effectively to deliver critical detection systems for our homeland defense; and all statements in this press release constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include, without limitation, PositiveID's ability to successfully pursue the BioWatch Generation 3 opportunity; as well as other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on March 28, 2012, as amended on May 4, 2012, and 10-Qs filed on November 16, 2012, August 20, 2012, as amended on September 12, 2012, and May 14, 2012, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
CONTACT:
Allison Tomek
561-805-8000
atomek@positiveidcorp.com
Published at Investorideas.com News wire
More info on PSID
http://www.investorideas.com/CO/PSID/
Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . Disclosure PSID is a featured company on Investorideas.com and has compensated the company in the past . Investorideas.com is currently long PSID shares. www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

OTC Automotive Stock Alert; Five Axis Expands Scion Program with MWW Automotive (OTCQB: MWWC)

HOWELL, Mich. - February 6, 2013 (Investorideas.com newswire) MWW Automotive Group (OTCQB: MWWC), a global design, engineering, and manufacturing firm, serving the world's leading automotive and industrial manufacturers, announced today that Five Axis has significantly expanded its relationship with the firm for their entire Scion Five:AD accessory line of products.

After Five Axis has successfully concluded its intense due diligence, has validated MWW's pre-production process and experienced the high quality of the first MWW production deliveries of Five: AD products, Troy Sumitomo, CEO of Five Axis has awarded the production painting and fulfillment logistics of the Five:AD Scion FR-S, Scion TC and Scion IQ programs to MWW Automotive. Production for the FR-S and TC has already begun and first shipments have been successfully delivered. The Scion IQ will follow shortly. The programs consist of Front Air Dams, Rear Spoilers, Side Skirts and Rear Spats for the Scion FR-S, The Scion IQ and the Scion TC.
These are mid-size production volume programs and MWW has also been charged to manage all inventory and delivery logistics for Five Axis. This ranges from raw material inventory to on-demand and drop shipments to the large Five Axis distributing network, including the large Toyota Vehicle Processing Centers and Five Axis Toyota retailers all across the US.
"We are extremely pleased that Troy Sumitomo has decided to award these programs to MWW," states Chuck Pinkerton, CEO of MWW Automotive. This will allow us to assign dedicated re-finishing production lines and teams to the Scion products and produce even more effectively for Five Axis, in order to satisfy their extremely high quality and logistics requirements. Chuck Pinkerton continues:"This kind of highly specialized production capability that is required for these extremely high-end and custom designed Five:AD accessory products is our core competency and reflects our commitment to provide the highest production quality in the industry to our customers in this market segment."
About Five Axis
Founded in 1995 by Troy Sumitomo, Five Axis is a high-end design and prototype studio located in Southern California. For well over a decade, the Five Axis team of designers and fabricators has developed, engineered and fabricated some of the world's most amazing concept show cars. Five Axis' team of world-class designers has also turned its attention to the automotive aftermarket with its FIVE:AD line of aftermarket styling products. Designed and crafted with the same meticulous attention to detail as its world-renowned Five Axis concept cars, FIVE:AD (which stands for "Five Axis Design") products make it possible for the discriminating enthusiasts to own a growing line of aero kits, spoilers, wheels and other styling accessory parts with the highest quality fitment and finish available. For more information on the FIVE:AD product line visit http://www.fivead.net.
About MWW Automotive Group (OTCQB: MWWC)
The MWW Automotive Group's (MWWC) administrative offices are located in Howell, Michigan, with a 40,000 square foot Class A manufacturing and logistics facility in Baroda, Michigan for the production of high quality OE automotive and industrial products. MWW delivers its products and Class A painting, assembly and logistics services directly to major US and Foreign automobile manufacturers' Vehicle Processing Centres (VPC), leading edge show car and performance accessory design firms, and/or assembly lines in North America. MWW's industrial products are delivered directly to the industrial manufacturers for installation in their facilities. MWW provides substantial added value to the sale of vehicles and industrial products for leading international automobile and industrial manufacturers such as Toyota, Chevrolet, Hyundai, Kia Motors, MAZDA, GM, Ford, FIVE AXIS and their strategic partners ROUSH Performance and Polytec/FOHA. For more information visit www.mwwautomotive.com or e-mail investorrelations@mwwautomotive.com
Safe Harbor Statement: Certain statements in this press release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified by the use words such as "anticipate," "believe," "expect," "future," "may," "will," "would," "should," "plan," "projected," "intend," and similar expressions. Such forward-looking statements, involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. The Company's future operating results are dependent upon many factors, including but not limited to the Company's ability to: (i) obtain sufficient capital or a strategic business arrangement to fund its expansion plans; (ii) build the management and human resources and infrastructure necessary to support the growth of its business; (iii) competitive factors and developments beyond the Company's control; and (iv) other risk factors discussed in the Company's periodic filings with the Securities and Exchange Commission, which are available for review at www.sec.gov under "Search for Company Filings."

Published at Investorideas.com newswire

Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas.com has been compensated for news release distribution and publishing on its affiliates and partners: equivalent of six thousand in 144 shares.
http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Medical Technology Breaking News: Aethlon Medical (OTCBB:AEMD) Note: Since September 30th, 2011 / Thank You Shareholders

SAN DIEGO - February 5, 2013 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD), today released the following note authored by its Chairman and CEO, Jim Joyce.

In our quest to innovate life-saving therapeutics, we have persevered through untold challenges to create a single medical device that offers to optimize the benefit of cancer and infectious disease therapies. As our endeavors transitioned beyond R&D, we thought we were cognizant of the entire alphabet soup of healthcare and financial regulatory agencies we would need to navigate to bring our technology to market.
However, on September 30th 2011, we were blindsided by an action never anticipated. The Depository Trust Company (DTC) eliminated the electronic transfer of our securities, otherwise known as a "DTC Chill." As a result, broker-dealers across America began to restrict or prohibit trading in Aethlon Medical shares, which in turn reduced liquidity and inhibited the true sentiment for our company to be accurately reflected by the public markets. A recently published viewpoint of a securities law firm provides a more succinct perspective on a DTC Chill:
"The Depository Trust Company is the only stock depository in the U.S. When DTC provides services as the depository for an issuer's securities, its securities can trade electronically. Without DTC eligibility, it is almost impossible for an issuer to establish an active market in its securities."
As the result of protracted legal effort, DTC has agreed to lift the restriction on the electronic transfer of our securities, which we reported in an SEC filing on January 7th. In a related event, I am pleased to inform shareholders and other interested parties that our transfer agent has notified us that the CUSIP underlying our shares is now unlocked to again allow for our shares to be electronically traded on the DTC system. Thus, signaling the end of a lengthy and disheartening challenge faced by our organization.
While we cannot measure the full impact the DTC Chill, I ask you to consider some of our milestone achievements since September 30th, 2011. Milestone achievements that many biotechnology or medical device organizations would envy.
On the day (yes, the exact same day) the DTC Chill went into effect, we transitioned from a development-stage to revenue-stage organization as the result of a $6.8 Department of Defense (DOD) contract award from the Defense Advanced Research Projects Agency (DARPA). Since contract initiation, we have generated in excess of $2 million in revenues and have advanced the development of a device and blood processing system to combat sepsis.
Related to our DARPA program, we teamed with two larger industry organizations to respond to a $25 million systems integrator contract opportunity. The recipient of this contract has not yet been announced by DARPA.
We reported our first Hepatitis-C (HCV) efficacy data related to the use of our Hemopurifier® as an adjunct to optimize the benefit of standard of care drug therapy. The results exceeded expectations as a three-treatment Hemopurifier® protocol was demonstrated to reduce viral load to undetectable levels in as little as seven days. Since September 30th, 2011, organizations with clinical stage adjunct therapies have been acquired for a much as $11 Billion.
Based on prior discussions with the U.S. Food and Drug Administration (FDA), we established a protocol to elute the post-treatment biological fluid from the Hemopurifier® as a means to quantify HCV capture. The result established an unprecedented data point validating the capture of up to 300 billion copies of HCV during a single treatment. I plan to detail the relevance of this datapoint in a future CEO note.
As the result of our HCV treatment outcomes, the Medanta Medicity Institute is now offering Hemopurifier® therapy on a compassionate-use basis to HCV-infected individuals.
We submitted an Investigational Device Exemption (IDE) to the FDA to request permission to initiate a clinical feasibility study HCV infected individuals who would be enrolled to receive Hemopurifier® therapy. We have since received comments and study design considerations back from FDA and are preparing a response that we hope will lead to the initiation of U.S. clinical studies.
Since September 30th, 2011, we advanced studies that validated the ability of our Hemopurifier® to capture exosomes underlying different forms of cancer. Tumor-secreted exosomes have been discovered to play a vital role in cancer progression and it has recently become clear that a successful war against cancer will need to address these particles. Our Hemopurifier® is the first therapeutic candidate to address tumor-secreted exosomes.
We expanded our intellectual property portfolio of pending and issued patents. As the result of our early exosome research, we were recently issued a patent that protects our cancer treatment strategy in the United States for the next two decades.
We disclosed that researchers at the Morehouse School of Medicine discovered that the Hemopurifier® captures HIV exosomes, which transport NEF protein to assist HIV in maintaining the suppression of the immune system, even when antiviral drugs are able to achieve undetectable viral load in treated patients.
We began shipping our exosome assay (ELLSA), which we originally created to support our own research, to researchers who are utilizing its capabilities to create new diagnostic tools that have the potential to identify a variety of disease conditions in blood and urine.
We received the support of highly regarded thought leaders from the extracorporeal, sepsis, and cancer field who agreed to join our science advisory board.
We believe that these selected achievements portray a company that is making significant progress despite the challenges of being a small public company that was saddled with a DTC Chill since September 30th, 2011.
In closing, I am forever grateful to those shareholders that have loyally supported our endeavors even in the darkest moments. Your belief validates many sacrifices and inspires the strength to continue waging every fight necessary to ensure our innovation has the opportunity to save lives.
About Aethlon Medical
Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT� System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system. At present, The Aethlon ADAPT� product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer, and a medical device being developed under a 5-year contract with Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers. For more information, please visit www.aethlonmedical.com.
About The Aethlon Hemopurifier®
The Aethlon Hemopurifier® is a first-in-class medical device that selectively targets the rapid clearance of infectious viral pathogens and immunosuppressive proteins from the entire circulatory system. In the treatment of Hepatitis C virus (HCV), human studies have demonstrated that Hemopurifier® therapy may improve immediate, rapid and sustained virologic response rates when administered in the first few days of standard-of-care drug therapy. In addition to accelerating viral load depletion, post-treatment analysis of the Hemopurifier® has documented the capture of up to 300 billion HCV copies of HCV during a single six-hour treatment. Access to Hemopurifier® therapy is available on a compassionate-use basis through the Medanta Medicity Institute (Medicity), a leading center for medical tourism in India. The Medicity is offering treatment access to infected individuals who previously failed or subsequently relapsed standard-of-care drug regimens. The Hemopurifier® is also being offered as a salvage therapy to infected individuals who suffer a viral breakthrough during standard-of-care therapy. U.S. studies of the Hemopurifier® are currently pending approval of an IDE submitted to FDA.
The Aethlon Hemopurifier® and Cancer
In addition to the opportunity to address a broad-spectrum of infectious viral pathogens, the Hemopurifier® has been discovered to capture tumor-derived exosomes underlying several forms of cancer. Tumor-derived exosomes have recently emerged to be a vital therapeutic target in cancer care. These microvesicular particles suppress the immune response in cancer patients through apoptosis of immune cells and their quantity in circulation correlates directly with disease progression. Beyond possessing immunosuppressive properties, tumor-derived exosomes facilitate tumor growth, metastasis, and the development of drug resistance. By addressing this unmet medical need, the Hemopurifier® is positioned as an adjunct to improve established cancer treatment regimens.
Certain statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, that the company can successfully protect its intellectual property, that removal of exosomes from the human body will impact or lead to successful treatment of cancer, or that exosomes are the cause of tumor growth and progression, that the FDA will not approve the initiation of the Company's clinical programs or provide market clearance of the company's products, future human studies whether revenue or non-revenue generating of the Aethlon ADAPT™ system or the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer or hepatitis C therapies or as a standalone cancer or hepatitis C therapy, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Contacts:
James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
Marc Robins
877.276.2467
mr@aethlonmedical.com
Published at Investorideas.com Newswire
More info on AEMD at Investorideas.com Visit: http://www.investorideas.com/CO/AEMD/
Disclaimer: Investorideas.com is a third party publisher of news and research. Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. If you have any questions regarding information in this press release please contact the company listed in the press release. Aethlon Medical, Inc. is currently an annual news release client at Investorideas.com and compensates Investorideas.com $2425 quarterly to publish and distribute news with Investorideas and its syndication partners
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Calpian's (OTCQB: CLPI) Emerging Market Mobile Payments Solution Grows to Approximately $11.9 Million in Processed Transaction Volume in January

DALLAS - February 5, 2013 (Investorideas.com mobile payment stocks newswire) Calpian, Inc. (OTCQB:CLPI) announces that, as of January 31, 2013, the Money-on-Mobile service offered by its Indian subsidiary is now being supported by over 122,340 retail locations, increased from 118,000 on December 31, 2012, and accessed by approximately 35.8 million unique phone number customers, up from the 32.5 million reported from the previous month. The January 2013 processed transaction volume, measured in Indian rupees, was 636.7 million INR – an approximate 16 million increase over December 2012 processed volume. At current exchange rates, January processed transaction volume was approximately $11.9 million.

"Since our initial investment in Money-on-Mobile in April 2012, we’ve seen consistent monthly growth in both the number of users and of retailers embracing Money-on-Mobile as their preferred method of mobile payment,” says Calpian CEO, Harold Montgomery. “It’s exciting to see such a positive trend and to offer a product that is so easily accessible to the massive Indian population."
About Calpian, Inc.
Calpian, Inc. (OTCQB:CLPI) is a publicly traded company with corporate offices in Dallas, Texas and mobile payments emerging-market operations through its subsidiary in India. Calpian's U.S. business focuses on the 10,000 Independent Sales Organizations (ISOs) that serve approximately 2 million small merchants across all industries in the U.S. who pay an estimated $1 billion in annual residuals. Calpian’s Indian subsidiary offers Money-on-Mobile, a pre-paid mobile payment solution, to over 32.5 million unique Indian phone number customers at more than 118,000 Indian retail locations. Calpian's management team has over 70 years in combined experience in the payments business. Calpian's CEO, Harold Montgomery, is a recognized industry leader who has provided expert testimony to the U.S. Congress and Federal Reserve Bank on payments-related issues and regularly appears in numerous industry publications, such as Transaction World Magazine. Please visit our website at www.calpian.com for more information.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy, liquidity, and building a larger credit facility. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Contact:
Calpian, Inc.
Cynthia Bailey, 214-758-8600
Chief Marketing Officer
cbailey@calpian.com
or
Company Contact:
Harold Montgomery, 214-758-8600
CEO
haroldmontgomery@calpian.com
or
Investor Relations Contact:
John Liviakis, 415-389-4670
john@Liviakis.com

Published at Investorideas.com newswire
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure : Calpian ( OTC:CLPI) compensates Investorideas.com for news publishing and distribution and company profile : effective December 19th 2012 : five thousand per month and restricted 144 shares. http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Profiting from Water Stocks; Investorideas.com and Water Expert Neil Berlant Bundle Services for Water Sector

Point Roberts WA- February 1, 2013 (www.investorideas.com newswire, www.water-stocks.com ) Investorideas.com, an investor research portal specializing in sector research for independent investors, is pleased to announce new services for the publicly traded water sector.

Investorideas.com, one of the few investor research portals that covers the water sector, has partnered with well- known water expert, Neil Berlant to build on and enhance its current online services. Investorideas.com and www.water-stocks.com will continue to showcase public companies online, publish press releases, write commentary on stocks in the sector and interview leading experts.  Mr. Neil Berlant will create a new division for institutional and accredited investor introductions to qualified water companies.

Future plans also include water investment conferences, both live and online and water stocks research in the form of a newsletter to subscribers.

“We have interviewed Neil many times over the years and featured him in our online conferences; always turning to him as a well- known and respected source in the water investment community. It’s exciting to look to the year ahead and work with Neil to build the needed recognition for the water sector and help public companies build their brand with the right investors “ said  Investorideas.com founder.  

Neil Berlant recently said, “My goal is to have investors recognize and appreciate, in one more way, the often overlooked value and importance of water.  As I define the water industry, it’s all things that influence the quality and availability of water.”

Investorideas.com currently offers one of the most comprehensive water stock directories available to individual investors, listing over global 300 stocks in a PDF format.

Research water stocks with the water stocks directory at Investorideas.com
http://www.investorideas.com/Water-Stocks/Stock_List.asp

Neil D. Berlant
Partner,Crowell, Weedon & Co.
Since 1968, Neil has been continuously involved in the investment banking industry, either as a principal, officer, or founder of several firms. He has supervised and initiated the publication of numerous investment research reports on the water industry and conducted conferences directed towards top corporate management, the investment community, and venture capitalists. He has been a speaker at conferences on topics ranging from financing, to business and investment opportunities in the water industry. In addition, he has consulted to Fortune 500 companies and participated in negotiations concerning mergers, acquisitions, and venture capital investments. He is quoted frequently in newspapers including the Wall Street Journal, The New York Times, Los Angeles Times, Investor's Business Daily, and frequently appears on CNBC and other stations.

Neil Berlant Interview on Bloomberg – Profiting from Water
Nov. 2 - Neil Berlant, a partner at Cromwell Weedon & Co., talks with Bloomberg's Deirdre Bolton about how to profit by investing in water assets. They speak on Bloomberg Television's "Money Moves."
http://www.bloomberg.com/video/liquid-money-profiting-from-water-wNq7oNCFTEyVwD_lyfF7eQ.html


About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more . 
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com


Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp

Become an Investorideas.com Member and access our 14 online stock directories 24/7 – water, renewable energy, mining stocks and more…
http://www.investorideas.com/membership/

Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894


For more info and ideas on investing in water contact Investor Ideas 

800-665-0411 - Source – www.Investorideas.com

Mining Stock News: SilverCrest (TSX.V: SVL) (NYSE MKT: SVLC) Appoints Vice President, Corporate Development

VANCOUVER, BRITISH COLUMBIA - January 31, 2013 (Investorideas.com Mining Stocks Newswire) SilverCrest Mines Inc. (TSX.V:SVL) ( NYSE MKT: SVLC) (CW5.F) ("SilverCrest" or the "Company") is pleased to announce the appointment of Mr. Marcio Fonseca (P.Geo.) to the newly created position of Vice President, Corporate Development. In his new position, Mr. Fonseca will be responsible for developing, implementing and executing all aspects of SilverCrest''s corporate development opportunities designed to accelerate the Company''s growth and enhance its shareholder''s value. Mr. Fonseca''s responsibilities will be to forge new and strengthen existing relationships with institutional and retail investors, source and evaluate opportunities for corporate and property acquisitions, develop and implement corporate financial strategies and raise the corporate profile of the Company in the general investment community through marketing and presentation of the Company''s assets and plans for growth

Mr. Fonseca has more than 20 years of experience in international mine finance, corporate and project evaluation. Most recently Mr. Fonseca was a Division Director in Macquarie Metals and Energy Capital (Canada) ltd, where he developed a successful career over the last 9 years, focused on equity and debt financing for the mining sector. Mr. Fonseca has been directly involved in successful mining financings for the development of mining projects worldwide. Prior to that, Mr. Fonseca held corporate positions in business development, project development, operations and exploration with Vale and Phelps Dodge in Latin America. Mr. Fonseca holds a Bachelor of Science degree in Geology from The Federal University of Minas Gerais - Brazil, Specialization in Engineering Economics from Fundação Dom Cabral-Brazil and an MSc in Mineral Project Appraisal from the Royal School of Mines, Imperial College, London. Mr. Fonseca''s experience combines valuation, financing, operations and project management. Mr. Fonseca will be part of the SilverCrest''s team, helping to create a solid foundation for growth.
J. Scott Drever, President of the Company, commented: "We are delighted that Mr. Fonseca has chosen to join SilverCrest''s senior management team. Mr. Fonseca''s broad skill set and experience in international mining finance and project development will be extremely valuable in the advancement of the Company''s position as a mid-tier precious metals producer."
The company also announces the grant of incentive stock options to purchase 350,000 common shares of SilverCrest which are exercisable at $2.60 per share, have a five year term and are subject to vesting in accordance with applicable Company policies.
SilverCrest Mines Inc. (TSX-V: SVL; NYSE MKT: SVLC) is a Canadian precious metals producer headquartered in Vancouver, BC. SilverCrest's flagship property is the 100%-owned Santa Elena Mine, located 150 km northeast of Hermosillo, near Banamichi in the State of Sonora, Mexico. The mine is a high-grade, epithermal gold and silver producer, with an estimated life of mine cash cost of US$8 per ounce of silver equivalent (55:1 Ag:Au). SilverCrest anticipates that the 2,500 tonnes per day facility should recover approximately 4,805,000 ounces of silver and 179,000 ounces of gold over the 6.5 year life of the open pit phase of the Santa Elena Mine. A three year expansion plan is underway to double metals production at the Santa Elena Mine and exploration programs are rapidly advancing the definition of a large polymetallic deposit at the La Joya property in Durango State.
FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking statements" within the meaning of Canadian securities legislation and the United States Securities Litigation Reform Act of 1995. Such forward-looking statements concern the Company's anticipated results and developments in the Company's operations in future periods, planned exploration and development of its properties, plans related to its business and other matters that may occur in the future. These statements relate to analyses and other information that are based on expectations of future performance, including silver and gold production and planned work programs. Statements concerning reserves and mineral resource estimates may also constitute forward-looking statements to the extent that they involve estimates of the mineralization that will be encountered if the property is developed and, in the case of mineral reserves, such statements reflect the conclusion based on certain assumptions that the mineral deposit can be economically exploited.
Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements, including, without limitation: risks related to precious and base metal price fluctuations; risks related to fluctuations in the currency markets (particularly the Mexican peso, Canadian dollar and United States dollar); risks related to the inherently dangerous activity of mining, including conditions or events beyond our control, and operating or technical difficulties in mineral exploration, development and mining activities; uncertainty in the Company's ability to raise financing and fund the exploration and development of its mineral properties; uncertainty as to actual capital costs, operating costs, production and economic returns, and uncertainty that development activities will result in profitable mining operations; risks related to reserves and mineral resource figures being estimates based on interpretations and assumptions which may result in less mineral production under actual conditions than is currently estimated and to diminishing quantities or grades of mineral reserves as properties are mined; risks related to governmental regulations and obtaining necessary licenses and permits; risks related to the business being subject to environmental laws and regulations which may increase costs of doing business and restrict our operations; risks related to mineral properties being subject to prior unregistered agreements, transfers, or claims and other defects in title; risks relating to inadequate insurance or inability to obtain insurance; risks related to potential litigation; risks related to the global economy; risks related to the Company's status as a foreign private issuer in the United States; risks related to all of the Company's properties being located in Mexico and El Salvador, including political, economic, social and regulatory instability; and risks related to officers and directors becoming associated with other natural resource companies which may give rise to conflicts of interests. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the forward-looking statements. The Company's forward-looking statements are based on beliefs, expectations and opinions of management on the date the statements are made. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.
The information provided in this news release is not intended to be a comprehensive review of all matters and developments concerning the Company. It should be read in conjunction with all other disclosure documents of the Company. The information contained herein is not a substitute for detailed investigation or analysis. No securities commission or regulatory authority has reviewed the accuracy or adequacy of the information presented.
J. Scott Drever, President
SILVERCREST MINES INC.
Contact:
SilverCrest Mines Inc.
Fred Cooper
(604) 694-1730 ext. 108
Toll Free: 1-866-691-1730
(604) 694-1761 (FAX)
info@silvercrestmines.com
www.silvercrestmines.com
570 Granville Street, Suite 501
Vancouver, British Columbia V6C 3P1
Published at Investorideas.com Newswire
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: SilverCrest Mines has compensated Investorideas.com for the distribution and publishing of this news release (annual news publication 9700) http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

The Carbon Footprint of Stevia; Industry Leaders Truvia, Sunwin Stevia (OTCQB: SUWN) and PureCircle (LSE: PURE.L) Aim for new Levels of Efficiency and Sustainability

Point Roberts, WA - January 31, 2013 (Investorideas.com Newswire) Investorideas.com, an investor research portal specializing in sector research for independent investors, issues an industry alert on stevia and its environmentally friendly production.

The Truvia business reported earlier in January that its Truvia calorie-free sweetener is the first stevia-based sweetener to be awarded product carbon footprint certification. The certification arm of the UK-based Carbon Trust has certified the total greenhouse gas emissions at every stage of the supply chain, including cultivation, processing, packaging, transport and use and disposal.
Under the certification, the Truvia business has signed up to use the carbon reduction label in the future. By displaying this label, which in this case covers UK, USA, Mexico, Spain, France, Italy, the Truvia brand is committed to reducing the carbon footprint of its sweetener over a two year period.
In 2010, the Truvia business made a number of sustainability pledges.
Commitments include:

• To reduce its carbon footprint by 50% in 2015 from a 2010 baseline to become carbon neutral in 2020
• To ensure all processed water is returned to the same quality in which it was taken and reduces net depletion by 25% by 2020
• To reduce waste by 50% across the supply chain in 2015 in efforts to become zero waste by 2020

Sunwin Stevia International, Inc. (OTCQB: SUWN) is an industry leader in agricultural processing and recently announced a new stevioside extraction line that uses a state of the art crystallization process that substantially reduces the production time while increasing product yield.
Sunwin is one of the top global providers of high quality stevia extracts including Rebaudioside A 98, and its facilities are now capable of producing A3-99 stevia products. The addition of A3-99 to its commercial production capabilities is part of its previously announced stevioside expansion project.
According to the Global Stevia Institute, stevia requires lower inputs of land, water, and energy to produce the same amount of sweetness found in other natural sweeteners. Sunwin Stevia's added efficiency in production will improve an already low carbon footprint.
Sunwin (OTCQB: SUWN) began its expansion project in April 2012 in anticipation of an improvement in demand, in the coming years, as the use of stevia as a healthy low calorie sweetener continues to increase across the globe. Sunwin has begun trial production of its new lines and anticipates its additional production capabilities will be fully operational in the third quarter of 2013.
PureCircle Limited (LSE: PURE.L) released a whitepaper last year that its high purity stevia sweeteners have a carbon footprint that is as much as 82% lower and a water footprint that is as much as 97% lower than other publicly available sweetener benchmarks. PureCircle's findings were based on measurements of the 2011 fiscal year production of its high purity sweeteners. The footprints were conducted by Camco, UK, a leading independent water and carbon footprint expert, and further peer-reviewed by leading footprint experts, Dr. Tim Hess of Cranfield University, UK and Zahir Lazcano, an independent consultant.
The Global Stevia Institute also notes, "Stevia's great tasting, zero-calorie sweetness not only can be part of a healthful diet, it can be part of a more environmentally friendly diet too. Several aspects of stevia's environmental advantage can be linked to its sweetness potency. Stevia's sweet components, steviol glycosides, can be up to 400 times sweeter than sugar. This high sweetness level can allow for greater efficiencies and smaller environmental impact in stevia sweetener production, from farming to the finished ingredient.
Stevia requires lower inputs of land, water, and energy to produce the same amount of sweetness found in other natural sweeteners. Also, since stevia crops generally require less land, many stevia farmers still grow other crops and maintain agricultural diversity, an important component of environmental sustainability and healthy ecosystems.
By choosing the natural sweetness of stevia, consumers can help people maintain a healthful and environmentally-friendly diet—and that is something that consumers, health professionals, and food producers can truly feel good about." http://globalsteviainstitute.com
About. Sunwin Stevia International, Inc. ( OTCQB: SUWN). Sunwin Stevia International, Inc. (OTCQB: SUWN) engages in the areas of zero calorie, all natural sweeteners (Sunwin Stevia™ Extracts). As an industry leader in agricultural processing, Sunwin Stevia has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. For more info about Sunwin Stevia, please visit http://www.sunwininternational.com
Research more Agriculture stocks at Investorideas.com
http://www.investorideas.com/MSS/Arg_Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Sign up for the free investor news and stock alerts at Investorideas.com
http://www.investorideas.com/Resources/Newsletter.asp
More Sunwin info at Investorideas.com http://www.investorideas.com/CO/SUWN/
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: Investorideas.com is compensated by China Direct on behalf of SUWN, averaging four thousand per week for news publication, dissemination and profile on Invesotrideas.com , its affiliate news and email sites http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com

Follow the Money in Mobile Commerce in India; Calpian (CLPI) , Western Union Company (WU) and Citigroup (C)

Point Roberts, WA - January 31, 2013 (Investorideas.com mobile payment stocks newswire) Investorideas.com, a leader in sector research for independent investors, issues a sector snapshot for the mobile commerce sector in India. With data supporting mobile payments on the rise in India, new players are entering the market, with different approaches and solutions for Indian consumers. Calpian(OTCQB:CLPI) and Western Union (NYSE:WU) are addressing the needs of the millions of underbanked Indians, while Citibank, a subsidiary of Citigroup, Inc. (NYSE:C), builds on the services of 320 million card customers in India.

Calpian (OTCQB:CLPI) strategically placed itself in India in March 2012 with its investment in its subsidiary, Money-on-Mobile, that allows users to make simple financial transactions for anyone with a text-enabled phone.
Calpian recently reported that, as of December 31, 2012, Money-on-Mobile is now being supported by over 118,000 retail locations and has been accessed by approximately 32.5 million unique phone number customers since April 1, 2012. The December 2012 processed transaction volume, measured in Indian rupees, was 620.4 million INR - an approximate 90 million increase over November 2012 processed volume. At current exchange rates, December processed transaction volume was approximately $11.4 million.
Cynthia Bailey, Chief Marketing Officer of Calpian(OTCQB:CLPI) notes, "part of the problem in India is that most of the population, well over 50 percent according to a 2012 Mastercard study, do not even have a bank account, much less a credit card, so our solution addresses the issue of "financial inclusion" to allow these unbanked people the ability to pay their bills, send money to other individuals, etc. Previously, they had to rely on cash which was not a safe, fast or particularly effective method to use."
The Western Union Company (NYSE:WU) has addressed the same problem, joining forces with ICICI Bank and MasterCard last October to launch the Western Union® ICICI Bank Prepaid Card in India.
The card offers millions of underbanked Indians - many who carry cash 24/7 - a safe way to store and access their money anytime along with new options for saving and spending.
"Western Union's vision is to promote financial inclusion in India with ICICI Bank and MasterCard," said Mike Hafer, Senior Vice President, Global Prepaid, Western Union. "The new card will give Indians benefits similar to those offered by mainstream banked cards without the restrictions of maintaining an average daily balance limit or being denied for creditworthiness."
Citibank, a subsidiary of Citigroup, Inc. (NYSE:C), announced earlier this month the launch of a fully integrated and certified mobile payment solution in India and across the Citigroup network, globally. The mobile payment solution, developed by Citi's partner, Ezetap Mobile Solutions, allows for more than 320 million card customers in India to make payments through their debit and credit cards at the point- of- payment. The secured paperless transaction not only does away with managing charge slips but also combines the many benefits enjoyed by Citibank card customers, including instant redemption of reward points, accelerated rewards as well as the ability to opt for the popular EMI payment option while using this new payment alternative. Merchant partners using this device for customer payments and collections will be given real time information during the payment and collection process, providing an integrated, secured and efficient receivables payment solution.
"Our partnerships with leading brands in India stand testimony to the fact that the solution is already a market leader driving digital payments in our country," said Muge Yuzuak, country head of Cards and Personal Loans, Citibank India. "We believe that this payment and collection device has the potential to dramatically increase the penetration of card terminals from the current low level of 700,000 units in India."
Cynthia Bailey, Chief Marketing Officer of Calpian (OTCQB:CLPI) commented following the news, "it sounds like it's a solution that will enable people who already have credit cards and bank accounts to make mobile payments at the point- of -sale - if there were more cardholders and point- of- sale terminals, this might be a good option, but that really isn't the problem. The problem is, it's a big country with a huge population of individuals who are basically excluded from the banking/credit/electronic payment system completely, and this is not a solution that will address that while Money-on-Mobile does ."
The industry is poised for explosive growth. According to Calpian this is a $200 Billion opportunity. Google India recently reported that 30 per cent of online shopping queries last year came from mobile phones. A recent article in Businesstoday.com notes that month-on-month transactions carried out through mobile banking are surging both in volume and value terms but consumers in India have not yet fully embraced mobile payments. So it may come to who has the easiest solutions and services to convince consumers.
Article source : http://businesstoday.intoday.in/story/mobile-banking-on-the-rise-in-india/1/191851.html
About Calpian (OTCQB: CLPI)
Calpian, Inc. (CLPI) is a publicly traded company with corporate offices in Dallas, Texas and mobile payments emerging-market operations through its subsidiary in India. Calpian's U.S. business focuses on the 10,000 Independent Sales Organizations (ISOs) that serve approximately 2 million small merchants across all industries in the U.S. who pay an estimated $1 billion in annual residuals. Calpian's Indian subsidiary offers Money-on-Mobile, a pre-paid mobile payment solution, to over 32.5 million unique Indian phone number customers at more than 118,000 Indian retail locations. Calpian's management team has over 70 years in combined experience in the payments business. Calpian's CEO, Harold Montgomery, is a recognized industry leader who has provided expert testimony to the U.S. Congress and Federal Reserve Bank on payments-related issues and regularly appears in numerous industry publications, such as Transaction World Magazine. www.calpian.com and http://www.money-on-mobile.net/ for more information.
Follow CLPI on Twitter: http://twitter.com/CalpianInc
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com
Article source: http://www.business-standard.com/india/news/m-payment-industry-in-india-to-touch-115-billion-by-2016/199779/on
Forward Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.
Disclaimer/ Disclosure : Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: CLPI has compensated Investor Ideas effective December 19 th: five thousand per month and 144 stocks.
More info: http://www.investorideas.com/About/Disclaimer.asp
http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source - www.Investorideas.com, Calpian, Inc

Mobile Security Technology Company NXT-ID, Inc. Reports Funding Commitment from Connecticut Innovations

Shelton, Conn - January 31, 2013 (Investorideas.com mobile payment stocks newswire) NXT-ID, Inc, a mobile commerce and security technology company reports it has received $150,000 in funding commitments from Connecticut Innovations.

Connecticut Innovations (CI), the state's quasi-public authority responsible for growing Connecticut businesses through innovative financing and strategic assistance, announced this week that it has committed funding totaling $650,000 through its Pre-Seed Fund to four startup companies focused on information technology, digital media and mobile technology:
eBrevia Inc. ( Stamford, Conn.) - $150,000 funding commitment
MedAdherence™ LLC ( Norwalk, Conn.) - $200,000 funding commitment
MediaCrossing Inc. ( Stamford, Conn.) - $150,000 funding commitment
NXT-ID Inc. ( Shelton, Conn.) - $150,000 funding commitment
"These new investments reflect the strong startup activity taking place in Fairfield County," said Claire Leonardi, chief executive officer and executive director of CI. "We are excited to support these promising ventures and look forward to seeing an even stronger pipeline of startups in the area as Connecticut's new Stamford-based business accelerator, which is part of the state's Innovation Ecosystem, gets underway. Building a strong technology community in Fairfield County and throughout the state through well-placed investments is a high priority of the Malloy administration."
"We are grateful for the support of CI," said Gino Pereira, chief executive officer of NXT-ID. "CI has funded investments since 1995 solely on returns made from their prudent investments and we are proud to be among their portfolio companies.
About Connecticut Innovations Inc.
Connecticut Innovations (CI) is a quasi-public corporation providing equity, debt and bond financing and other forms of financial assistance to companies in all stages of the business life cycle, from startup to later stage. CI offers its portfolio companies strategic guidance and collaborations with partners in business, finance, education, government and nonprofit sectors. CI's initiatives are designed to grow the state's economic and technology base, and to stimulate business investments and job creation. For more information on CI, please visit www.ctinnovations.com .
About NXT-ID, Inc
NXT-ID, Inc.'s innovative MobileBio Ô solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms. NXT-ID is building an innovative, next generation platform using advanced biometric technology to enable secure transactions, identity management and access control via mobile and other devices in an intuitive, cost-effective and easy-to-use manner.
http://www.nxt-id.com/
Contact
Gino Pereira
Chief Executive Officer
Phone: 203-242-3076;
Fax: 203-888-7399
Email: gino@nxt-id.com
Published at www.Investorideas.com newswire
Investorideas.com 8006650411
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: NXT-ID is a private company currently compensating Investorideas.com for online marketing.

Medical Technology Breaking News: Aethlon Medical (OTCBB:AEMD) Discloses CEO Interview

SAN DIEGO - January 29, 2013 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD), today disclosed that a recent interview our Chairman and CEO, Jim Joyce participated in with the UT San Diego radio network is now available on-line.

Mr. Joyce was interviewed on the Brian Britt Show which is broadcast on the UT San Diego radio network. The interview is available at http://bit.ly/UTSanDiego-BrianBrittShow-JimJoyce-Aethlon. Part one of the interview is on podcast number 03 and the second part is on podcast number 04.
About Aethlon Medical
Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system. At present, The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer, and a medical device being developed under a 5-year contract with Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers. For more information, please visit www.aethlonmedical.com.
About The Aethlon Hemopurifier®
The Aethlon Hemopurifier® is a first-in-class medical device that selectively targets the rapid clearance of infectious viral pathogens and immunosuppressive proteins from the entire circulatory system. In the treatment of Hepatitis C virus (HCV), human studies have demonstrated that Hemopurifier® therapy may improve immediate, rapid and sustained virologic response rates when administered in the first few days of standard-of-care drug therapy. In addition to accelerating viral load depletion, post-treatment analysis of the Hemopurifier® has documented the capture of up to 300 billion HCV copies of HCV during a single six-hour treatment. Access to Hemopurifier® therapy is available on a compassionate-use basis through the Medanta Medicity Institute (Medicity), a leading center for medical tourism in India. The Medicity is offering treatment access to infected individuals who previously failed or subsequently relapsed standard-of-care drug regimens. The Hemopurifier® is also being offered as a salvage therapy to infected individuals who suffer a viral breakthrough during standard-of-care therapy. U.S. studies of the Hemopurifier® are currently pending approval of an IDE submitted to FDA.
The Aethlon Hemopurifier® and Cancer
In addition to the opportunity to address a broad-spectrum of infectious viral pathogens, the Hemopurifier® has been discovered to capture tumor-derived exosomes underlying several forms of cancer. Tumor-derived exosomes have recently emerged to be a vital therapeutic target in cancer care. These microvesicular particles suppress the immune response in cancer patients through apoptosis of immune cells and their quantity in circulation correlates directly with disease progression. Beyond possessing immunosuppressive properties, tumor-derived exosomes facilitate tumor growth, metastasis, and the development of drug resistance. By addressing this unmet medical need, the Hemopurifier® is positioned as an adjunct to improve established cancer treatment regimens.
Certain statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, that the company can successfully protect its intellectual property, that removal of exosomes from the human body will impact or lead to successful treatment of cancer, or that exosomes are the cause of tumor growth and progression, that the FDA will not approve the initiation of the Company's clinical programs or provide market clearance of the company's products, future human studies whether revenue or non-revenue generating of the Aethlon ADAPT™ system or the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer or hepatitis C therapies or as a standalone cancer or hepatitis C therapy, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Contacts:
James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
Marc Robins
877.276.2467
mr@aethlonmedical.com
Published at Investorideas.com Newswire
More info on AEMD at Investorideas.com Visit: http://www.investorideas.com/CO/AEMD/
Disclaimer: Investorideas.com is a third party publisher of news and research. Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. If you have any questions regarding information in this press release please contact the company listed in the press release. Aethlon Medical, Inc. is currently an annual news release client at Investorideas.com and compensates Investorideas.com $2425 quarterly to publish and distribute news with Investorideas and its syndication partners
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Mining Stock News: SilverCrest (TSX.V: SVL) (NYSE MKT: SVLC) Announces Updated La Joya Resources

VANCOUVER, BRITISH COLUMBIA - January 29, 2013 (Investorideas.com Mining Stocks Newswire) SilverCrest Mines Inc. (TSX.V:SVL) ( NYSE MKT: SVLC) (CW5.F) ("SilverCrest" or the "Company") is pleased to announce an updated resource estimation for the La Joya Property in Durango, Mexico. The updated Inferred Resources are summarized as (refer to tables below for details);

• Cutoff grade of 15 gpt silver equivalent (Ag Eq*,Global Case): 198.6 million ounces Ag Eq
• Cutoff grade of 30 gpt Ag Eq (Base Case); 159.8 million ounces Ag Eq
• Cut-off grade of 60 gpt Ag Eq (High Grade Case); 100.8 million ounces of Ag Eq
• Cut-off grade of 0.05% WO3; 75.1 million pounds (35,700 tonnes) of tungsten

The Company believes that the 60 gpt Ag Eq portion of the deposit with an estimated tonnage of 27.9 million tonnes grading 112 grams per tonne Ag Eq* constitutes a priority area to be examined as a potential "Starter Pit" for initial conceptual operations that will be examined in the Preliminary Economic Assessment (PEA) to be commenced shortly. The La Joya Property has excellent potential for additional resources with the deposits being open in most directions. Further infill and expansion drilling is recommended to increase and convert resources from Inferred to Indicated.
These resources have been independently estimated by EBA Engineering Consultants Ltd., a Tetra Tech Company utilizing Company Phase I and Phase II drill results and surface sampling programs along with independently-validated historic data. Drilling to date has been relatively widespread in the Main Mineralized Trend (MMT) as well as the independent deposits of Coloradito and Santo Nino. The MMT which includes the Phase I and II drilling areas, has a length of 2.5 kilometres and an average minimum width of over 700 metres (see attached Figures - http://media3.marketwire.com/docs/svl129_F1-2.pdf).
The La Joya resource models separate the deposits into two broad categories based on the predominant mineralogy. The first category is comprised of silver, gold and copper mineralization (AgCu Rich Zone), with lesser amounts of tungsten (WO3), molybdenum (Mo), lead (Pb), and Zinc (Zn). The second category is predominantly tungsten and molybdenum mineralization (Contact Zone) with lesser amounts of Ag, Cu, Au, Pb, and Zn. The mineralogy of these categories is often gradational and overprinted in some areas. The AgCu Rich Zone generally lies spacially above the Contact Zone and generally follows the contours of the underlying intrusive, which outcrops in several areas. The summaries of the resource estimates below show the resources attributed to each of these mineralization categories for each of the current deposits, specifically, the MMT, Santo Nino, and Coloradito.
* Silver equivalency includes silver, gold and copper and excludes lead, zinc, molybdenum and tungsten values. Ag:Au is 50:1, Ag:Cu is 86:1, based on 5 year historic metal price trends of US$24/oz silver, US$1200/oz gold, US$3/lb copper. 100% metallurgical recovery is incorporated until further information is available.
**Classified by EBA, A Tetra Tech Company and conforms to NI 43-101, 43-101CP, and CIM definitions for resources. All numbers are rounded. Inferred Resources have been estimated from geological evidence and limited sampling and must be treated with a lower level of confidence than Measured and Indicated Resources. Mineralization boundaries used in the interpretation of the geological model and resource estimate are based on a cutoff grade of 15 gpt Ag Eq using the metal price ratios described above.
* WO3 is based on a standard calculation of tungsten (W) times 1.26. 100% metallurgical recovery is incorporated until further information is available.
** Classified by EBA, A Tetra Tech Company and conforms to NI 43-101, 43-101CP, and CIM definitions for resources. All numbers are rounded. Inferred Resources have been estimated from geological evidence and limited sampling and must be treated with a lower level of confidence than Measured and Indicated Resources. Mineralization boundaries used in the interpretation of the geological model and resource estimate are based on a cutoff grade of 200 ppm W.
Much of the Contact Zone resource is considered to be near-surface and potentially amenable to conventional open pit mining. This zone also contains gold, silver, copper and tin (as defined by geochemistry) which may add secondary value as a result of increased metal content.
These resource estimates are based on recent and historical information collected by SilverCrest Mines and previous operators (Luismin/Goldcorp) from 1979 to present. Phase II Company drilling comprising 78 holes (25,812.65 metres), the 26 holes Phase I Company drilling (5,753.70 metres) in addition to 18 validated historic drillholes (5,907.26 metres) were included in the geological database used as source data for the estimation. Drill hole spacing for the 122 holes (37,473.61 metres) used in the resource estimation is approximately 75 metres.
Based on available data and computer modeling, the current dominant mineralization at La Joya is hosted within numerous sub-vertical, near east-west striking structurally-controlled stockwork zones. These zones are considered to be semi-continuous along strike with true widths ranging from 15 to 50 metres using a cutoff grade of 15 gpt Ag Eq. Eight near-horizontal mantos (semi-continuous disseminated stratabound sulphides) have been modeled within the resource area, which are cross-cut by the stockwork zones and considered the second dominant mineralization. The La Joya deposits are currently interpreted to host three related styles of mineralization. Please refer to News Release dated October 17, 2011 for defined types of mineralization at La Joya.
Initial metallurgical test work as reported in the first Technical Report on the property dated February 20, 2012 suggests that the La Joya deposit may be amenable to conventional flotation processes for copper concentrating with high grade silver and gold components. Significant metallurgical test work is being completed by an independent qualified lab to confirm flotation amenability and fully determine recoveries. The nearby Sabinas Mine (Penoles), which is considered to be a similar deposit style to La Joya, has been in production for many years and is currently producing at an estimated rate of 4,000 tonnes/day and shipping flotation concentrate overseas.
The La Joya Inferred Mineral Resource Estimate was completed using Gemcom GEMS modeling software and is compliant with National Instrument 43-101 and conforms to guidelines and definitions established by the Canadian Institute of Mining and Metallurgy. The resource is based on verified information from historical and recent company sources. The Mineral Resources include block models for the Main Mineralized Trend and Santo Nino located within Cerro Sacrificio, and for Cerro Coloradito. Solid boundaries for the mineralization were interpreted using a minimum 15 Ag Eq cut-off from drill holes composites. Raw assay data was composited to 2 metres and was interpolated into a 5 metre x 5 metre x 5 metre block size model using inverse distance squared methodology with multiple mineralized domains and search ellipses. The search ellipse ranges were based on geological field observation, geostatistical analysis and iterative interpolation. Grade caps of 550 gpt Ag, 5.5 gpt Au and 6.0 % Cu were determined from histogram analysis and applied after compositing. Grade interpolation within stratabound manto mineralization utilized an anisotropic search ellipse oriented along the interpreted trend of bedding with major and semi-major axis ranges of 75 metres and a minor axis range of 40 metres. Where manto grades exceeded 120 gpt Ag, 1 gpt Au, or 1% Cu, the search ellipse was limited to major and semi-major axis ranges of 40 metres, and a minor axis range of 20 metres. Grade interpolation within sub-vertical structurally-controlled stockwork zones utilized an anisotropic ellipse oriented along the interpreted zones with major and semi-major axis ranges of 80 metres and a minor axis range of 30 metres. A minimum of 2 composites, to a maximum of 15, were required to interpolate block grades with no more than 3 composites reporting from any one drill hole in manto mineralization, or no more than 3 composites reporting from any one drill hole in the stockwork zones. Based on limited laboratory and in situ testing, a value of 3 was applied as a specific gravity for all materials in the model. Using the definitions in the CIM Definition Standards for Mineral Resources and Mineral Reserves, all Mineral Resources have been classified as being Inferred based on the number of samples used for estimation relative to the deposit area and the overall confidence in interpretation from the widely spaced drill holes for this style of deposit. Inferred Resources should not be used as the basis for evaluation of economic viability of the project. Details of these criteria will be presented in the Technical Report to be filed on SEDAR.
The independent Qualified Persons for the La Joya resource estimation who have reviewed and approved the contents of this news release are James Barr., P.Geo., and Lara Reggin, P.Geo. both from the consulting firm of EBA Engineering Consultants Ltd., a Tetra Tech Company and Ting Lu, P.Eng. (for Metallurgy) from Wardrop Engineering, a Tetra Tech Company. A Technical Report currently being prepared by the Qualified Persons and will adhere to the disclosure requirements of NI 43-101 and will be filed no later than 45 days from the date of this release.
SilverCrest Mines Inc. (TSX-V: SVL; NYSE MKT: SVLC) is a Canadian precious metals producer headquartered in Vancouver, BC. SilverCrest's flagship property is the 100%-owned Santa Elena Mine, located 150 km northeast of Hermosillo, near Banamichi in the State of Sonora, Mexico. The mine is a high-grade, epithermal gold and silver producer, with an estimated life of mine cash cost of US$8 per ounce of silver equivalent (55:1 Ag:Au). SilverCrest anticipates that the 2,500 tonnes per day facility should recover approximately 4,805,000 ounces of silver and 179,000 ounces of gold over the 6.5 year life of the open pit phase of the Santa Elena Mine. A three year expansion plan is underway to double metals production at the Santa Elena Mine and exploration programs are rapidly advancing the definition of a large polymetallic deposit at the La Joya property in Durango State.
FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking statements" within the meaning of Canadian securities legislation and the United States Securities Litigation Reform Act of 1995. Such forward-looking statements concern the Company's anticipated results and developments in the Company's operations in future periods, planned exploration and development of its properties, plans related to its business and other matters that may occur in the future. These statements relate to analyses and other information that are based on expectations of future performance, including silver and gold production and planned work programs. Statements concerning reserves and mineral resource estimates may also constitute forward-looking statements to the extent that they involve estimates of the mineralization that will be encountered if the property is developed and, in the case of mineral reserves, such statements reflect the conclusion based on certain assumptions that the mineral deposit can be economically exploited.
Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements, including, without limitation: risks related to precious and base metal price fluctuations; risks related to fluctuations in the currency markets (particularly the Mexican peso, Canadian dollar and United States dollar); risks related to the inherently dangerous activity of mining, including conditions or events beyond our control, and operating or technical difficulties in mineral exploration, development and mining activities; uncertainty in the Company's ability to raise financing and fund the exploration and development of its mineral properties; uncertainty as to actual capital costs, operating costs, production and economic returns, and uncertainty that development activities will result in profitable mining operations; risks related to reserves and mineral resource figures being estimates based on interpretations and assumptions which may result in less mineral production under actual conditions than is currently estimated and to diminishing quantities or grades of mineral reserves as properties are mined; risks related to governmental regulations and obtaining necessary licenses and permits; risks related to the business being subject to environmental laws and regulations which may increase costs of doing business and restrict our operations; risks related to mineral properties being subject to prior unregistered agreements, transfers, or claims and other defects in title; risks relating to inadequate insurance or inability to obtain insurance; risks related to potential litigation; risks related to the global economy; risks related to the Company's status as a foreign private issuer in the United States; risks related to all of the Company's properties being located in Mexico and El Salvador, including political, economic, social and regulatory instability; and risks related to officers and directors becoming associated with other natural resource companies which may give rise to conflicts of interests. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the forward-looking statements. The Company's forward-looking statements are based on beliefs, expectations and opinions of management on the date the statements are made. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.
The information provided in this news release is not intended to be a comprehensive review of all matters and developments concerning the Company. It should be read in conjunction with all other disclosure documents of the Company. The information contained herein is not a substitute for detailed investigation or analysis. No securities commission or regulatory authority has reviewed the accuracy or adequacy of the information presented.
J. Scott Drever, President
SILVERCREST MINES INC.
Contact:
SilverCrest Mines Inc.
Fred Cooper
(604) 694-1730 ext. 108
Toll Free: 1-866-691-1730
(604) 694-1761 (FAX)
info@silvercrestmines.com
www.silvercrestmines.com
570 Granville Street, Suite 501
Vancouver, British Columbia V6C 3P1
Published at Investorideas.com Newswire
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: SilverCrest Mines has compensated Investorideas.com for the distribution and publishing of this news release (annual news publication 9700) http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894